Literature DB >> 12370148

Epicutaneous patch testing.

Steven A Devos1, Pieter G M Van Der Valk.   

Abstract

Epicutaneous patch testing is still regarded as the best method of diagnosing allergic contact dermatitis. The present patch test technique is the result of a continuous process of development and improvement since its first application in the late 19th century. During the last decades of the 20th century a lot of effort was put into standardization of materials and methods used in patch testing. Patch tests can be used to confirm a suspected allergic contact dermatitis and either to recommend avoidance of particular products or to recommend alternative products in a particular patient. The true rate of clinically relevant hypersensitivity in positive patch test reactions remains to a great extent unknown. The ideal patch test should cause as few adverse reactions as possible, but a lot of adverse reactions have been described. How-ever, it has to be noted that the overall risk-benefit equation of patch testing is in favor of the benefit, if performed correctly and with the proper indications. A careful history taking and attention to the clinical picture are key actions to facilitate the interpretation of the clinical relevance of the epicutaneous patch test results.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12370148

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  4 in total

1.  Carbamazepine-induced acute generalized exanthematous pustulosis: a case report.

Authors:  Saadia Skalli; Pierre Barret; Céline Villier; Jean-François Bussières
Journal:  J Pediatr Pharmacol Ther       Date:  2011-01

2.  Drug hypersensitivity to previously tolerated phenytoin by carbamazepine-induced DRESS syndrome.

Authors:  Cheol-Woo Kim; Gwang-Seong Choi; Chang-Ho Yun; Deok-In Kim
Journal:  J Korean Med Sci       Date:  2006-08       Impact factor: 2.153

3.  A laboratory test based on determination of cytokine profiles: a promising assay to identify exposition to contact allergens and predict the clinical outcome in occupational allergic contact dermatitis.

Authors:  Valentina Bordignon; Francesca Palamara; Giorgia Altomonte; Isabella Sperduti; Mario Pietravalle; Claudia Cavallotti; Paola Cordiali-Fei; Maria Pia Fuggetta; Antonio Cristaudo; Fabrizio Ensoli
Journal:  BMC Immunol       Date:  2015-02-06       Impact factor: 3.615

4.  In Vitro Monitoring of Human T Cell Responses to Skin Sensitizing Chemicals-A Systematic Review.

Authors:  Marina Aparicio-Soto; Caterina Curato; Franziska Riedel; Hermann-Josef Thierse; Andreas Luch; Katherina Siewert
Journal:  Cells       Date:  2021-12-28       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.